Kohji Nishida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kohji Nishida has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Noriyasu Hashida
Ophthalmology, Osaka University, Suita, JPN
2 shared publications - Shizuka Koh
Department of Innovative Visual Science, The University of Osaka Graduate School of Medicine, Osaka, Japan
2 shared publications - Shizuka Takahashi
Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita 565-0871, Osaka, Japan
2 shared publications - Damien Gatinel
Adolphe de Rothschild Foundation Hospital, Paris, France
1 shared publication - Hirokazu Sakaguchi
Department of Ophthalmology and Visual Science, Hiroshima University, Hiroshima, Japan
1 shared publication - Kazuhiko Ohnuma
Laboratorio de Lente Verde, 98-1 Nozomino, Sodegaura, Chiba, 299-0251, Japan
1 shared publication
Latest Publications
- 29 September 2026
- Published by Wolters Kluwer Health in Eye & Contact Lens: Science & Clinical Practice
- Vol. 52 (11) , 460-465
Beyond Eye Rubbing: Mechanical Ocular Stimulation Is Highly Prevalent in Keratoconus
Objectives: To investigate current and previous mechanical ocular stimulation behaviors beyond conventional eye rubbing in patients with keratoconus. Methods: This prospective study included Japanese outpatients with a clinical diagnosis of keratoconus in at least one eye. All participants completed a structured investigator-developed questionnaire assessing current and past mechanical ocular stimulation behaviors, followed by face-to-face physician interviews. Questionnaire items included history, reasons, duration, frequency, techniques, and anatomical sites of stimulation. Results: A total of 304 patients were included, with 91.4% reporting mechanical ocular stimulation. These behaviors were typically long-standing (75.9% >10 years) and varied widely in motivation, frequency, methods, and anatomical sites. Ocular itching was the most common trigger (75.9%), although many behaviors were unrelated to itching. Finger pulp (56.1%) and knuckles (48.6%) were commonly used, and the medial canthus was the most commonly involved site (70.1%) ( P <0.05). Pressure-related behaviors, such as eye pressing or massage during fatigue, were reported by approximately one third of patients. Conclusions: The concept of mechanical ocular stimulation provides a more comprehensive framework than eye rubbing for characterizing pressure-related behaviors in patients with keratoconus. Broader assessment of current and past behaviors may improve clinical assessment and patient counseling.
- 29 September 2026
- Published by Wolters Kluwer Health in Eye & Contact Lens: Science & Clinical Practice
- Vol. 52 (11) , 460-465
Beyond Eye Rubbing: Mechanical Ocular Stimulation Is Highly Prevalent in Keratoconus
Objectives: To investigate current and previous mechanical ocular stimulation behaviors beyond conventional eye rubbing in patients with keratoconus. Methods: This prospective study included Japanese outpatients with a clinical diagnosis of keratoconus in at least one eye. All participants completed a structured investigator-developed questionnaire assessing current and past mechanical ocular stimulation behaviors, followed by face-to-face physician interviews. Questionnaire items included history, reasons, duration, frequency, techniques, and anatomical sites of stimulation. Results: A total of 304 patients were included, with 91.4% reporting mechanical ocular stimulation. These behaviors were typically long-standing (75.9% >10 years) and varied widely in motivation, frequency, methods, and anatomical sites. Ocular itching was the most common trigger (75.9%), although many behaviors were unrelated to itching. Finger pulp (56.1%) and knuckles (48.6%) were commonly used, and the medial canthus was the most commonly involved site (70.1%) ( P <0.05). Pressure-related behaviors, such as eye pressing or massage during fatigue, were reported by approximately one third of patients. Conclusions: The concept of mechanical ocular stimulation provides a more comprehensive framework than eye rubbing for characterizing pressure-related behaviors in patients with keratoconus. Broader assessment of current and past behaviors may improve clinical assessment and patient counseling.
- Open Access
- 27 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 5073
An Association between HTRA1 and TGF-β2 in the Vitreous Humor of Patients with Chorioretinal Vascular Diseases
Background: The aim of this paper was to investigate the protein concentrations of high-temperature requirement A 1 (HTRA1) and transforming growth factor- (TGF-) in the vitreous humor of patients with chorioretinal vascular diseases. Methods: This study measured protein concentrations of HTRA1, TGF-, and vascular endothelial growth factor A (hereinafter called VEGF) in the vitreous humor from seven eyes of patients with chorioretinal vascular diseases (age-related macular degeneration, diabetic macular edema, and retinal vein occlusion) and six control eyes (idiopathic epiretinal membrane and macular hole). We analyzed the mutual relationship among the protein levels. Results: The protein levels of HTRA1 and VEGF were significantly increased in the chorioretinal vascular disease group compared with the control group (1.57 ± 0.79 mol/mL vs. 0.68 ± 0.79 mol/mL, p = 0.039; 3447.00 ± 3423.47 pg/mL vs. 35.33 ± 79.01 pg/mL, p = 0.046, respectively). TGF- levels were not significantly different between groups (2222.71 ± 1151.25 pg/mL for the chorioretinal vascular disease group vs. 1918.83 ± 744.01 pg/mL for the control group, p = 0.62). The concentration of HTRA1 was strongly associated with TGF- levels in the vitreous humor, independent of VEGF (r = 0.80, p = 0.0010). Conclusions: We revealed that vitreous HTRA1 was increased in patients with chorioretinal vascular diseases and strongly correlated with TGF-.- 27 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 5073
Open AccessAn Association between HTRA1 and TGF-β2 in the Vitreous Humor of Patients with Chorioretinal Vascular Diseases
Background: The aim of this paper was to investigate the protein concentrations of high-temperature requirement A 1 (HTRA1) and transforming growth factor- (TGF-) in the vitreous humor of patients with chorioretinal vascular diseases. Methods: This study measured protein concentrations of HTRA1, TGF-, and vascular endothelial growth factor A (hereinafter called VEGF) in the vitreous humor from seven eyes of patients with chorioretinal vascular diseases (age-related macular degeneration, diabetic macular edema, and retinal vein occlusion) and six control eyes (idiopathic epiretinal membrane and macular hole). We analyzed the mutual relationship among the protein levels. Results: The protein levels of HTRA1 and VEGF were significantly increased in the chorioretinal vascular disease group compared with the control group (1.57 ± 0.79 mol/mL vs. 0.68 ± 0.79 mol/mL, p = 0.039; 3447.00 ± 3423.47 pg/mL vs. 35.33 ± 79.01 pg/mL, p = 0.046, respectively). TGF- levels were not significantly different between groups (2222.71 ± 1151.25 pg/mL for the chorioretinal vascular disease group vs. 1918.83 ± 744.01 pg/mL for the control group, p = 0.62). The concentration of HTRA1 was strongly associated with TGF- levels in the vitreous humor, independent of VEGF (r = 0.80, p = 0.0010). Conclusions: We revealed that vitreous HTRA1 was increased in patients with chorioretinal vascular diseases and strongly correlated with TGF-. - Open Access
- 19 April 2023
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 44 (2) , e216-e218
Cytomegalovirus-Induced Optic Neuritis Through Cerebrospinal Fluid Viral Transmission in an Immunocompetent Patient: A Case Report
- 19 April 2023
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 44 (2) , e216-e218
Open AccessCytomegalovirus-Induced Optic Neuritis Through Cerebrospinal Fluid Viral Transmission in an Immunocompetent Patient: A Case Report
- Open Access
- 4 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33368
Idiopathic Multicentric Castleman Disease Presenting With Hypertensive Choroidopathy: A Case Report
Castleman disease (CD) is a lymphoproliferative disorder and rarely affects ocular tissue. This study aimed to report a case of hypertensive choroidopathy in a patient with Castleman’s disease associated with malignant hypertension. A 39-year-old man visited his local physician with fever, systemic edema, and multiple lymphadenopathies. An inguinal lymph node biopsy indicated CD. One month after the biopsy, the patient noted a blurring of vision. At the time of the initial examination at our hospital, his best-corrected visual acuity (BCVA) was 20/20 in both eyes but there were bilateral multiple Elschnig spots and sprinter hemorrhage at the fundus. Swept-source optical coherence tomography showed intra-retinal fluid, and serous retinal detachment (SRD). Fluorescein angiography revealed multiple punctate hyper fluorescences and indocyanine green angiography showed choroidopathy with increased vascular permeability. A general examination revealed symptoms of cardiac failure and multiple lymphadenopathies. Malignant hypertension with acute glomerulonephritis was diagnosed after a renal biopsy. After antihypertensive treatment, his blood pressure (BP) improved, and the SRD and choroidopathy promptly resolved. Presently, the patient is being followed up without complications. We report a case of hypertensive choroidopathy in a patient with CD associated with malignant hypertension. As a severe elevation in BP can damage choroidal vasculature and lead to vision loss, careful observation and active treatment are necessary.
- 4 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33368
Open AccessIdiopathic Multicentric Castleman Disease Presenting With Hypertensive Choroidopathy: A Case Report
Castleman disease (CD) is a lymphoproliferative disorder and rarely affects ocular tissue. This study aimed to report a case of hypertensive choroidopathy in a patient with Castleman’s disease associated with malignant hypertension. A 39-year-old man visited his local physician with fever, systemic edema, and multiple lymphadenopathies. An inguinal lymph node biopsy indicated CD. One month after the biopsy, the patient noted a blurring of vision. At the time of the initial examination at our hospital, his best-corrected visual acuity (BCVA) was 20/20 in both eyes but there were bilateral multiple Elschnig spots and sprinter hemorrhage at the fundus. Swept-source optical coherence tomography showed intra-retinal fluid, and serous retinal detachment (SRD). Fluorescein angiography revealed multiple punctate hyper fluorescences and indocyanine green angiography showed choroidopathy with increased vascular permeability. A general examination revealed symptoms of cardiac failure and multiple lymphadenopathies. Malignant hypertension with acute glomerulonephritis was diagnosed after a renal biopsy. After antihypertensive treatment, his blood pressure (BP) improved, and the SRD and choroidopathy promptly resolved. Presently, the patient is being followed up without complications. We report a case of hypertensive choroidopathy in a patient with CD associated with malignant hypertension. As a severe elevation in BP can damage choroidal vasculature and lead to vision loss, careful observation and active treatment are necessary.
- Open Access
- 1 June 2022
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 48 (11) , 1305-1311
Preliminary demonstration of a novel intraocular lens power calculation: the O formula
Purpose: To evaluate the performance of a new formula of intraocular lens (IOL) power calculation (the O formula) based on ray tracing without commonly used parameters, including ultrasound-compatible axial length, keratometry readings, and A-constant. Setting: Tokyo Medical Center, Tokyo, Japan. Design: Retrospective consecutive case series. Methods: 423 eyes (423 patients) implanted with a single-piece, L-loop, acrylic IOL were enrolled. All biometric data for the O formula were obtained by anterior segment swept-source optical coherence tomography (SS-OCT) and SS-OCT–based biometer. The performance of the O formula was compared with those of the Barrett Universal II (BUII) and Kane formulas at 1 month postoperatively. Statistical analysis was applied according to a heteroscedastic test with SD of prediction errors as the main parameter for formula performance. Results: The SD of the O formula (0.426) was statistically significantly lower than that of the BUII formula (0.464, P = .034) but not statistically significantly different from that of the Kane formula (0.433, P = .601). The percentages of patients with refractive prediction errors within ±0.50 diopter (D) and ±1.00 D of the O, BUII, and Kane formulas were 75.4% and 98.6%, 77.1% and 97.9%, and 76.6% and 98.1%, respectively. Conclusions: The O formula, based on ray tracing using SS-OCT–based devices, is one of the promising approaches for IOL power calculation, although additional larger scale studies are needed. It may be used as an alternative in IOL power calculation because of its independence from commonly used parameters.
- 1 June 2022
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 48 (11) , 1305-1311
Open AccessPreliminary demonstration of a novel intraocular lens power calculation: the O formula
Purpose: To evaluate the performance of a new formula of intraocular lens (IOL) power calculation (the O formula) based on ray tracing without commonly used parameters, including ultrasound-compatible axial length, keratometry readings, and A-constant. Setting: Tokyo Medical Center, Tokyo, Japan. Design: Retrospective consecutive case series. Methods: 423 eyes (423 patients) implanted with a single-piece, L-loop, acrylic IOL were enrolled. All biometric data for the O formula were obtained by anterior segment swept-source optical coherence tomography (SS-OCT) and SS-OCT–based biometer. The performance of the O formula was compared with those of the Barrett Universal II (BUII) and Kane formulas at 1 month postoperatively. Statistical analysis was applied according to a heteroscedastic test with SD of prediction errors as the main parameter for formula performance. Results: The SD of the O formula (0.426) was statistically significantly lower than that of the BUII formula (0.464, P = .034) but not statistically significantly different from that of the Kane formula (0.433, P = .601). The percentages of patients with refractive prediction errors within ±0.50 diopter (D) and ±1.00 D of the O, BUII, and Kane formulas were 75.4% and 98.6%, 77.1% and 97.9%, and 76.6% and 98.1%, respectively. Conclusions: The O formula, based on ray tracing using SS-OCT–based devices, is one of the promising approaches for IOL power calculation, although additional larger scale studies are needed. It may be used as an alternative in IOL power calculation because of its independence from commonly used parameters.